U-69,593

U-69,593 is a synthetic opioid compound that acts as a selective kappa-opioid receptor agonist. It is primarily used in scientific research to study the effects of kappa-opioid receptor activation.
Pharmacology[edit]
U-69,593 is known for its high affinity and selectivity for the kappa-opioid receptor, a type of opioid receptor that is distinct from the more commonly known mu-opioid receptor. Activation of kappa-opioid receptors by agonists like U-69,593 can produce a range of effects, including analgesia, dysphoria, and diuresis.
Mechanism of Action[edit]
The primary mechanism of action of U-69,593 involves binding to and activating kappa-opioid receptors in the central nervous system. This activation leads to a cascade of intracellular events that result in the modulation of neurotransmitter release and neuronal excitability. Unlike mu-opioid receptor agonists, kappa-opioid receptor agonists like U-69,593 do not typically produce euphoria, which limits their potential for abuse.
Research Applications[edit]
U-69,593 is used extensively in research to explore the physiological and behavioral effects of kappa-opioid receptor activation. Studies have investigated its role in modulating pain perception, mood, and stress responses. Additionally, U-69,593 has been used to study the potential therapeutic applications of kappa-opioid receptor agonists in treating conditions such as depression, anxiety, and addiction.
Side Effects[edit]
The activation of kappa-opioid receptors by U-69,593 can lead to several side effects, including dysphoria, sedation, and hallucinations. These effects are attributed to the unique action of kappa-opioid receptor agonists on the brain's reward and stress pathways.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian